After successfully completing initial safety and feasibility trials, Quietmind Foundation, in cooperation with Texas A&M and Baylor Research Institute, are enrolling adults (50-85) with memory loss for a new innovative clinical study. 

About The Clinical Trial
In cooperation with Texas A&M University's Dept. of Neurosurgery, Quietmind Foundation is enrolling individuals age 50-85 years experiencing memory problems and who have been independently diagnosed with early to mid-stage dementia to participate in this trial. The study uses low-level light stimulation directed to the head. The stimulation sessions are conducted at home, twice daily, for 5 minutes over 60 consecutive days. The trial is randomized, placebo controlled and double blind.
Services Cost
All study-related services are provided at no cost and local travel costs are covered. 
Compensation 
After completing three, two-hour assessments all subjects are paid a total of $225. 
What's involved in this trial?
Individuals that match the clinical trial eligibility criteria will go through two unique assessments at the start, mid-point, and ending of the trial period. 

1. First, subjects will complete a Quantitative EEG assessment. This assessment involves wearing a cap with sensors that record the brain's electrical activity. This is a non-invasive procedure and completed in less than 30-minutes. This assessment is conducted in-person.
2. Secondly, subjects will complete a standardized memory assessment. This assessment will take an hour and is conducted remotely by the study neuropsychologist.

Following these first two assessments, participants will receive a light therapy device that they will wear for 5-minutes, twice daily for 2 months. This device uses safe LED lights that stimulate blood flow and reduce inflammation in the brain.

Participants re-do the EEG and cognitive assessments twice more during the two month trial.

Dr. Marvin Berman, PhD CBT is the founder of the Quietmind Foundation and leading the research trial.